Who
Kirk G. Nielsen
Director
Company insider
Files Form 4 as: Director, CVRx; Director and 10% owner, SpyGlass Pharma; Director and 10% owner, Inari Medical.
In numbers
- Trades disclosed
- 97
- Buys
- 18
- Sells
- 1
- Bought
- $8.0M
- Sold
- $25K
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 27 May 2020
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | CVRX CVRxMedical Devices | SEC FORM 4 Code A | —8,720 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | CVRX CVRxoption or derivative · Medical Devices | SEC FORM 4 Code A | —11,182 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | CVRX CVRxoption or derivative · Medical Devices | SEC FORM 4 Code A | —11,182 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | CVRX CVRxMedical Devices | SEC FORM 4 Code A | —8,720 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —1,690,230 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —548,067 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —548,067 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —1,690,230 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —548,067 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —548,067 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —359,255 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —359,255 | filing |
| 9 Feb 2026filed 10 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Code C | —1,690,230 | filing |
| 9 Feb 2026filed 10 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Code C | —548,067 | filing |
| 9 Feb 2026filed 10 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Code C | —548,067 | filing |
| 9 Feb 2026filed 10 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —9,689,922 | filing |
| 9 Feb 2026filed 10 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —3,142,015 | filing |
| 9 Feb 2026filed 10 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —3,142,015 | filing |
| 9 Feb 2026filed 10 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code C | —2,059,573 | filing |
| 9 Feb 2026filed 10 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Code C | —359,255 | filing |
News
SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL SystemSGP · manilatimes.net · 19 Oct 2026
0 headlines in the last 90 days name Kirk G. Nielsen; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.